Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06429813 · ClinicalTrials.gov registry record · NA

Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)

A NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer, sponsored by Paul Viscuse.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06429813 is a NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer that is actively recruiting participants, run by Paul Viscuse. The registered enrollment target is 24 participants, below the 186-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06429813, a NA study of Metastatic Prostate Cancer and Castrate Sensitive Prostate Cancer, is actively recruiting participants, sponsored by Paul Viscuse.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will enroll 24 patients who are starting ADT (Androgen Deprivation Therapy)/ARSI (Androgen-Receptor Signaling Inhibitors) therapy for newly diagnosed metastatic castrate-sensitive prostate cancer (mCSPC). All participants will be asked to complete 1-2 training sessions at UVA prior to starting the exercise. All participants will be asked to complete aerobic and strength testing before and after the exercise program. Participants will be asked to answer questionnaires throughout the program. The at-home exercise will last for 12 weeks.

Conditions Studied

Metastatic Prostate Cancer Castrate Sensitive Prostate Cancer

Interventions

  • BEHAVIORAL Home-Based Exercise Intervention - Walking
  • BEHAVIORAL Home-Based Exercise Intervention - HIIT Cycling

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-07-26
Est. Completion 2025-11
Phase NA

Sponsor

Paul Viscuse

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06429813

The ClinicalTrials.gov registry entry for NCT06429813 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 186-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Paul Viscuse, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Metastatic Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Home-Based Exercise Intervention - Walking is the first listed.

NCT06429813 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06429813 about?

NCT06429813 is a clinical study titled "Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)". This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will enroll 24 patients who are starting ADT (Androgen Deprivation Therapy)/ARSI (Androgen-Receptor Signaling Inhibitors) therapy for newly diagn...

What is the current status of trial NCT06429813?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-07-26. Estimated completion is 2025-11.

What conditions does trial NCT06429813 study?

This clinical trial studies the following conditions: Metastatic Prostate Cancer, Castrate Sensitive Prostate Cancer.

What interventions are being tested in trial NCT06429813?

The interventions under investigation include: Home-Based Exercise Intervention - Walking (BEHAVIORAL), Home-Based Exercise Intervention - HIIT Cycling (BEHAVIORAL).

Who is sponsoring clinical trial NCT06429813?

This trial is sponsored by Paul Viscuse, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06429813 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Metastatic Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Metastatic Prostate Cancer

All registered trials for this condition

Castrate Sensitive Prostate Cancer

All registered trials for this condition

Virginia

All trials with a study site in Virginia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.